SLAFX | SLARX | SLAFX / SLARX | |
Total Expense Ratio | 1.18 | 1.18 | 100% |
Annual Report Gross Expense Ratio | 1.33 | 1.33 | 100% |
Fund Existence | 33 years | 11 years | - |
Gain YTD | 34.088 | 34.074 | 100% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 281M | 281M | 100% |
Annual Yield % from dividends | 4.23 | 4.23 | 100% |
Returns for 1 year | 9.52 | 9.48 | 100% |
Returns for 3 years | 24.50 | 24.46 | 100% |
Returns for 5 years | 50.59 | 50.52 | 100% |
Returns for 10 years | 132.90 | 132.84 | 100% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
REPIX | 40.98 | 0.40 | +0.99% |
ProFunds Real Estate UltraSector Inv | |||
FBTAX | 30.03 | 0.26 | +0.87% |
Fidelity Advisor Biotechnology A | |||
FIJZX | 54.15 | -0.13 | -0.24% |
Fidelity Advisor Consumer Discret Z | |||
PWCIX | 88.75 | -0.23 | -0.26% |
Principal Capital Appreciation Inst | |||
TMITX | 11.34 | -0.06 | -0.53% |
Transamerica Mid Cap Growth I3 |